Kong Yonggang, Jiao Woer, Tao Zezhang, Chen Shiming
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Dec;35(12):1149-1152. doi: 10.13201/j.issn.2096-7993.2021.12.021.
Allergic rhinitis(AR) is a chronic non-infectious nasal mucosal disease mediated by IgE. It can be divided into seasonal and perennial according to the types of allergens.At present, there are many treatments for AR, among which allergen immunotherapy(AIT) is the only treatment option that can change the natural process of AR.AIT can improve innate immune response by reducing local hypertrophy, eosinophils, basophils and type 2 innate lymphocytes, and affect various T cells, B cells and many cytokines to regulate adaptive immunity. The mechanism of AIT on immune response is complex.In this review, the mechanism of immunotherapy on the innate and adaptive immunity of AR patients is highlighted, hoping to further understand the immunotherapy pathway of AR, and provide more theoretical basis for immunotherapy of AR.
变应性鼻炎(AR)是一种由IgE介导的慢性非感染性鼻黏膜疾病。根据变应原类型可分为季节性和常年性。目前,AR有多种治疗方法,其中变应原免疫疗法(AIT)是唯一能够改变AR自然病程的治疗选择。AIT可通过减少局部肥大、嗜酸性粒细胞、嗜碱性粒细胞和2型固有淋巴细胞来改善固有免疫反应,并影响各种T细胞、B细胞和多种细胞因子以调节适应性免疫。AIT对免疫反应的机制很复杂。在本综述中,重点阐述了免疫疗法对AR患者固有免疫和适应性免疫的机制,希望进一步了解AR的免疫治疗途径,并为AR的免疫治疗提供更多理论依据。